Gufic Biosciences Balance Sheet
- Market cap
- ₹4,237 crore
- P/E
- 57.7
- P/B
- 6.37
- ROE
- 10.1%
- Dividend yield
- 0.02%
As of Mar 2022, Gufic Biosciences had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings rose 259.08% from Mar 2023.
Gufic Biosciences balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 500 | 9.69 | 10.03 | 10.03 | 10.03 |
| Reserves | 8,500 | 267 | 352 | 421 | 484 |
| Borrowings | 1,200 | 334 | 333 | 336 | 405 |
| Other liabilities | 3,500 | 179 | 227 | 232 | 273 |
| Total liabilities | 13,700 | 861 | 1,093 | 1,169 | 1,342 |
| Fixed assets | 6,500 | 328 | 474 | 525 | 519 |
| Capital work in progress | 400 | 100 | 100 | 100 | 100 |
| Investments | 2,500 | 172 | 219 | 234 | 268 |
| Other assets | 4,300 | 258 | 328 | 351 | 403 |
| Total assets | 13,700 | 861 | 1,093 | 1,169 | 1,342 |
Balance sheet ratios
- Debt to equity
- 0.13
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Gufic Biosciences balance sheet — frequently asked questions
What is the total debt of Gufic Biosciences?
Gufic Biosciences reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹334 crore as of Mar 2023.
What is Gufic Biosciences' debt-to-equity ratio?
Based on the Mar 2022 balance sheet, Gufic Biosciences' debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.
What are Gufic Biosciences' total assets?
Gufic Biosciences' total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.
Same Data For Peers
Trade Gufic Biosciences With ATS
Track GUFICBIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.